Post-earnings recap
Reported
Thu, May 12, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix reported a narrower loss than expected with an EPS surprise of 21.74%. However, the stock fell by 1.97% following the earnings announcement, indicating that investors may have been looking for more positive signals or guidance, which was not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.18 | N/A | +21.74% |
| Revenue | $0 | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.